Wells Investment is a venture capital firm established in 2016 and located in Seoul, South Korea. The firm focuses on providing capital, management expertise, and network support to companies with promising potential across various sectors. Its investment interests include deep technology, information technology, bio-healthcare, services, commerce, hardware, materials, consumer goods, sustainability, commercial products, and business services. By leveraging its resources and industry knowledge, Wells Investment aims to foster the growth of innovative companies and contribute to advancements in multiple fields.
Honored is a tour operator that operates the domestic travel services.
Testworks
Series B in 2023
Testworks is a social enterprise company in Seoul, Korea. We create innovative solutions in AI data and software testing fields while providing an inclusive employment model for socially disadvantaged people. Our technical excellence ranges from AI data processing automation to manual software testing and review. We are recognized as the best-in-class data processing company for building high quality datasets used for AI training and verification.
Addd
Series A in 2023
ADDD operates a marketing platform that utilizes AI technology to enhance both online and offline advertising. The company specializes in analyzing outdoor video data to assess the demographics, including gender and age, of passersby, as well as their awareness and interest in advertisements. This real-time analysis is conducted through vision sensor cameras, which ensure data privacy by transmitting information directly to clients. Additionally, ADDD's platform optimizes media recommendations for advertisers, measuring the effectiveness of campaigns and automating the delivery of advertisements based on time and location. Through deep learning and art collaboration products, ADDD also provides clients with curated services that align with their specified budget for artwork.
Addd
Series A in 2023
ADDD operates a marketing platform that utilizes AI technology to enhance both online and offline advertising. The company specializes in analyzing outdoor video data to assess the demographics, including gender and age, of passersby, as well as their awareness and interest in advertisements. This real-time analysis is conducted through vision sensor cameras, which ensure data privacy by transmitting information directly to clients. Additionally, ADDD's platform optimizes media recommendations for advertisers, measuring the effectiveness of campaigns and automating the delivery of advertisements based on time and location. Through deep learning and art collaboration products, ADDD also provides clients with curated services that align with their specified budget for artwork.
Anipen
Series B in 2023
Anipen is a South Korean company focused on developing a 3D content platform that leverages augmented reality and deep learning technologies. The company specializes in creating applications for short video platforms and video games, enabling businesses to produce augmented reality web TV shows, social media promotional videos, and animated clips accessible on mobile devices. Anipen's innovative solutions facilitate the development of video communication and entertainment platforms, allowing enterprises to effectively promote their products and engage with their audiences.
GenKOre
Series A in 2022
GenKOre is a biotech company focused on developing innovative gene therapy solutions for medical emergencies. The company specializes in genetic scissors technology, which is integral to its healthcare platform. This platform not only provides gene therapy options but also includes educational programs that cover genome editing techniques, therapeutic approaches, and plant biotechnology. Through these offerings, GenKOre aims to enhance the genetic well-being of patients and the broader healthcare sector by providing valuable information and resources.
Studio Galilei
Seed Round in 2022
Studio Galilei is an SFO platform company that operates and manages mobility services.
HandHug
Series A in 2022
HandHug is a content commercialization company that operates an e-commerce platform designed to facilitate the creation and sale of products and brands in collaboration with creators. The company provides the necessary infrastructure for developing new products, enabling creators to build their brands effectively and market their offerings. By focusing on the intersection of content and commerce, HandHug aims to empower creators to monetize their work while offering consumers access to innovative products.
Crazy Alpaca
Seed Round in 2022
Crazy Alpaca is a technology company that offers a simulation analysis platform focused on the real estate sector. The app delivers comprehensive information on taxes, loans, interest rates, moving dates, and cash flow, utilizing big data and artificial intelligence to enhance real estate analysis. By leveraging advanced algorithms, Crazy Alpaca provides personalized recommendations and insights, helping users navigate the complexities of the real estate market more effectively. The platform aims to improve market infrastructure through accurate price predictions and tailored recommendations, making it a valuable resource for individuals and professionals in real estate.
Payta Lab
Series B in 2022
Payta Lab is a mobile payment platform focused on enhancing the ordering experience for customers and businesses. The platform allows for convenient non-face-to-face ordering by enabling customers to place and pay for their orders directly through their smartphones using near-field communication (NFC) and QR codes linked to their table. By analyzing customer demographics, consumption history, and regional economic activity, Payta Lab offers customized advertising, which helps restaurants increase sales per customer and improve store turnover while reducing labor costs. This innovative approach streamlines the ordering process and promotes a smarter culture of payment.
Around Double
Series A in 2022
Around Double sells apple watches and supersonic hair dryer products.
ReadNumber
Series A in 2021
ReadNumber specializes in providing financial accounting services tailored for self-employed individuals and startups. The company develops financial software that offers a range of functionalities, including sales management, profit and loss calculations, tax prediction, and tax processing. This software enables businesses to access management support and receive phone consultations for various financial concerns, facilitating better financial decision-making and planning.
Ingine
Series B in 2021
Ingine Inc. is a technology company based in Seoul, South Korea, founded in 2017. It specializes in developing a wave energy converter known as INwave, which efficiently converts tidal energy from waves into electricity. This innovative technology is particularly effective in shallow waters, where traditional converters face challenges. By harnessing the full range of wave movements, Ingine's solution enables clients to generate power reliably, expanding the potential for renewable energy generation in diverse marine environments.
Sendy
Series A in 2021
Sendy is a cloud-based logistics platform that provides on-demand freight transportation services.
Neurophet
Series B in 2021
Neurophet, Inc. is a neuroscience company based in Seoul, South Korea, founded in 2016. It specializes in developing innovative software solutions for brain stimulation and treatment of neurological disorders. The company's flagship product, Neurophet tES Lab, is a simulation software that calculates and visualizes the effects of brain stimulation by utilizing individual brain structures and specific stimulation conditions. Neurophet employs its proprietary Segengine technology, which can automatically segment brain magnetic resonance images into 107 distinct regions within a minute. This technology aids in predicting and investigating stimulation effects for conditions such as Alzheimer's disease, providing clinicians with a three-dimensional brain model and stimulation parameter guidance. By leveraging deep learning and numerical optimization techniques, Neurophet enables healthcare professionals to focus interventions on targeted regions of the brain, enhancing treatment efficacy for patients with brain diseases.
TeamFresh
Series C in 2021
TeamFresh is a cargo and freight company that provides logistics services.
Neuromeka
Series D in 2021
Neuromeka is a robotics technology company that specializes in developing collaborative robots designed for safe interaction with humans in manufacturing environments. The company aims to create a robot-as-a-Service (RaaS) platform, which facilitates the integration and operation of robotic automation for small and medium-sized manufacturing enterprises. By focusing on ease of use and safety, Neuromeka enables businesses to adopt robotic solutions without requiring specialized expertise, thus promoting accessibility in the automation sector. This innovative approach allows for versatile applications across various industries, enhancing productivity while ensuring a secure working environment.
Mezoo
Series A in 2021
Mezoo is a medical device manufacturing company focused on developing biomedical sensor technology aimed at enhancing human health through accurate diagnoses. The company has created a compact, patch-type electrocardiogram that can be affixed to a patient’s chest. This device monitors heart activity in real-time, allowing physicians to effectively manage and prevent heart disease. By providing essential health data, Mezoo's technology supports healthcare professionals in delivering timely and informed medical care.
Connext
Series A in 2021
Connext is a clinical-stage biotechnology platform focused on developing biological therapeutics in immuno-oncology and regenerative medicine. The company is working on treatments for rare diseases, with a pipeline that includes recombinant TLR5 agonists aimed at addressing radiation-induced conditions and recombinant collagenase for musculoskeletal disorders. By expanding treatment indications across oncology and dermatology, Connext seeks to enhance patient care and explore collaborative opportunities with global partners.
3billion
Series C in 2021
3billion, Inc. offers genetic testing and analysis services specifically designed for patients with rare diseases. Founded in 2016 and headquartered in Seoul, South Korea, the company aims to alleviate the challenges faced by these patients during the diagnostic process. By leveraging bioinformatics and machine learning technology, 3billion has significantly reduced the time and cost associated with genome interpretation, making comprehensive genetic testing more accessible. Their artificial intelligence-driven diagnostic services cover a wide range of genes and diseases, facilitating faster and more accurate diagnoses for healthcare providers, ultimately leading to improved health outcomes for patients.
Unique Good Company
Series A in 2021
Unique Good Company develops entertaining mobile apps.
RTBP ALLIANCE
Series A in 2021
RTBP ALLIANCE focuses on creating co-working spaces and modernize old places for local communities.
Payta Lab
Series A in 2020
Payta Lab is a mobile payment platform focused on enhancing the ordering experience for customers and businesses. The platform allows for convenient non-face-to-face ordering by enabling customers to place and pay for their orders directly through their smartphones using near-field communication (NFC) and QR codes linked to their table. By analyzing customer demographics, consumption history, and regional economic activity, Payta Lab offers customized advertising, which helps restaurants increase sales per customer and improve store turnover while reducing labor costs. This innovative approach streamlines the ordering process and promotes a smarter culture of payment.
DoctorHere
Series A in 2020
DoctorHere is a smart medical clinic using AI and IT to provide primary care both in-person and virtually
Sangsangwoori
Seed Round in 2020
Sangsangwoori is a staffing and recruiting company that operates a human resource platform designed to connect job seekers with employment opportunities. The company focuses on facilitating senior job placements through its platform, which leverages artificial intelligence to provide tailored recruitment information and recommendations. By targeting the retired workforce, Sangsangwoori aims to enhance social participation and promote re-employment, ultimately contributing to the development of a substantial middle-aged workforce.
Medihere
Series A in 2020
MEDIHERE exists to make it easier for doctors and patients to connect, in order to save the lives of more people. For this end, the company uses technology to enable board-certified physicians to provide more accessible and affordable primary care anytime, anywhere. Using the MEDIHERE app, patients now can easily meet up with doctors on text-based or video chat, without any prior appointment.
RTBP ALLIANCE
Series A in 2020
RTBP ALLIANCE focuses on creating co-working spaces and modernize old places for local communities.
Ziptoss
Series B in 2020
Ziptoss is transforming the South Korean real estate sector by offering a free brokerage service tailored for tenants. The company provides a platform that delivers transparent information and reliable offline fees, making the rental process more accessible. Ziptoss's application allows users to access online listings and advertisements while facilitating brokerage services specifically for foreigners. By gathering data directly from landlords, Ziptoss enables tenants to secure accommodations without incurring third-party fees, thereby streamlining the rental experience and enhancing transparency in the market.
Fount
Series B in 2020
Fount Inc. is an asset management Robo-Advisor company established in 2015 and headquartered in Seoul, South Korea. The firm specializes in providing customized financial portfolios through its advanced Robo-Advisor engine, Bluewhale, which utilizes AI technology and asset allocation theories to determine the optimal mix of assets. Fount's investing algorithm, driven by big data, assists clients in planning for various life events by promoting passive investing strategies that align with individual risk tolerance and time horizons. The company's tools enable clients to monitor financial markets and adjust their asset allocations in response to market fluctuations.
mangrove
Series A in 2020
mangrove is a real estate and rental services provider.
CastingN
Series A in 2020
CastingN Co., Ltd is an online sourcing platform based in Incheon, South Korea, established in 2015. It connects companies with professional subcontractors across various sectors, facilitating the outsourcing of services such as advertising, system development, web design, and accounting. The platform evaluates multiple factors, including company history, performance, and feedback, to identify the most suitable subcontractors for clients' needs. In addition to its matching services, CastingN offers programs for developing job-oriented content and conducting offline job training, enabling companies to work efficiently with specialized service providers.
Supaja
Series A in 2019
Supaja is an online educational platform that specializes in providing personalized 1-on-1 tutoring services. The company focuses on offering live mentoring for children from multicultural families, ensuring that students receive tailored academic support. By utilizing learning data from both education providers and students, Supaja effectively matches learners with tutors, fostering a customized learning experience that meets individual needs. This approach not only enhances academic performance but also promotes cultural understanding and inclusivity in education.
Mezoo
Seed Round in 2019
Mezoo is a medical device manufacturing company focused on developing biomedical sensor technology aimed at enhancing human health through accurate diagnoses. The company has created a compact, patch-type electrocardiogram that can be affixed to a patient’s chest. This device monitors heart activity in real-time, allowing physicians to effectively manage and prevent heart disease. By providing essential health data, Mezoo's technology supports healthcare professionals in delivering timely and informed medical care.
3billion
Series B in 2019
3billion, Inc. offers genetic testing and analysis services specifically designed for patients with rare diseases. Founded in 2016 and headquartered in Seoul, South Korea, the company aims to alleviate the challenges faced by these patients during the diagnostic process. By leveraging bioinformatics and machine learning technology, 3billion has significantly reduced the time and cost associated with genome interpretation, making comprehensive genetic testing more accessible. Their artificial intelligence-driven diagnostic services cover a wide range of genes and diseases, facilitating faster and more accurate diagnoses for healthcare providers, ultimately leading to improved health outcomes for patients.
NanudaKitchen
Series A in 2019
NanudaKitchen is a shared store & share kitchen platform that provides sales settlement, kiosk app solution and marketing services.
MDimune
Series B in 2019
MDimune Inc. is a therapeutics company based in Seoul, South Korea, established in 2015. It specializes in developing innovative drug delivery systems, particularly utilizing vesicles derived from immune and stem cells. The company focuses on creating targeted delivery methods to enhance the efficacy of treatments for conditions such as cancer, osteoarthritis, chronic obstructive pulmonary disease, and neurodegenerative diseases. MDimune's BioDrone platform enables the manufacture and supply of these vesicles, allowing biotechnology and pharmaceutical firms to develop novel therapeutics aimed at delivering drugs precisely to target tissues. This approach facilitates the provision of advanced anticancer therapies to patients, aligning with the company's mission to improve treatment outcomes through smart drug delivery solutions.
Perseus
Seed Round in 2019
Perseus Inc. specializes in the development of security software tailored for the automotive industry. Founded in 2016 and headquartered in Seoul, South Korea, with additional offices in San Jose, California, and Munich, Germany, the company focuses on enhancing automobile infrastructure through innovative hypervisor technology. This technology allows multiple applications to operate from a single System on Chip (SoC), significantly reducing the number of SoCs needed in connected cars, which can lead to substantial savings and a simpler, more secure ecosystem. The solutions offered by Perseus include a hypervisor-based security system that minimizes in-car hardware and software complexity, a secure container replicating ARM TrustZone functionality, and a Linux fast boot feature that accelerates boot-up times for embedded devices. The company ensures robust security with a guarantee of performance even in the event of an operating system attack, providing flexible and real-time control over security parameters.
3billion
Series A in 2018
3billion, Inc. offers genetic testing and analysis services specifically designed for patients with rare diseases. Founded in 2016 and headquartered in Seoul, South Korea, the company aims to alleviate the challenges faced by these patients during the diagnostic process. By leveraging bioinformatics and machine learning technology, 3billion has significantly reduced the time and cost associated with genome interpretation, making comprehensive genetic testing more accessible. Their artificial intelligence-driven diagnostic services cover a wide range of genes and diseases, facilitating faster and more accurate diagnoses for healthcare providers, ultimately leading to improved health outcomes for patients.
Zikto
Venture Round in 2018
ZIKTO is a wearable device company with motion tracking technology and bio-metric methods.
Moin
Series A in 2018
Moin, Inc. is a company based in Seoul, South Korea, that specializes in a blockchain-based foreign remittance solution. The firm offers a global money transfer service that is designed to be fast, convenient, and cost-effective, particularly focusing on countries in Asia. Moin's platform leverages blockchain technology to facilitate user-centric international remittance services, allowing customers to transfer money abroad efficiently and at reasonable charges.
Moin
Seed Round in 2017
Moin, Inc. is a company based in Seoul, South Korea, that specializes in a blockchain-based foreign remittance solution. The firm offers a global money transfer service that is designed to be fast, convenient, and cost-effective, particularly focusing on countries in Asia. Moin's platform leverages blockchain technology to facilitate user-centric international remittance services, allowing customers to transfer money abroad efficiently and at reasonable charges.
Woman’s Talk
Venture Round in 2017
Woman’s Talk is viewed by its users as a ‘friendly’ platform for the way in which it provides users with pricing and product related information. A key factor in the success of the business is the requirement for product brands to provide their most competitive price and product guarantee. Woman’s Talk in return provides a lower service fee compared to traditional distribution services whilst also providing the full marketing support required to promote the product.
G+FLAS Life Sciences
Series A in 2017
G+FLAS Life Sciences Co., Ltd., founded in 2014 and based in Seoul, South Korea, specializes in agricultural biotechnology with a focus on genome editing applications. Utilizing advanced CRISPR-Cas technology, the company develops innovative products such as glycoengineered humanized plants, which involve the selective removal of glycosylation-related genes. A flagship product is the vitamin D3-enriched tomato, aimed at enhancing nutritional value and addressing market demand for functional foods. This product not only serves the health-conscious consumer but also provides a plant-based alternative to traditional vitamin D supplements, catering to various dietary needs. G+FLAS has established a strategic partnership with Bayer, facilitating the commercialization of its technology and enhancing its position in the agricultural market. The company is also engaged in drug research and development, utilizing its gene therapy expertise to support healthcare organizations and pharmaceutical companies. G+FLAS Life Sciences is well-positioned for growth, targeting significant market share and aiming to accelerate expansion in the U.S. and beyond.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.